Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Inclusion criteria selected for patients with a diagnosis of epilepsy, an average of at least 2 seizures per month over the preceding 3 months prior to starting MAD, at least 18 years of age at the time of enrollment, having baseline carnitine lab measurement prior to starting MAD, and at least one carnitine lab measurement at a follow-up timepoint
doi: 10.2337/dc22-S009 3 GarberAJHandelsmanYGrunbergerGEinhornDAbrahamsonMJBarzilayJIet al
Best for: patients who want the lowest listed cash price and a low-dose tirzepatide option
Clinical trials show weight loss averaging 15-17% of body weight over a year
Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults (EQUATE)
1 2 "Drug Approval Package: Trulicity (dulaglutide) NDA #125469"
US$ 28.22
US$ 20.37
US$ 23.82
.png)
US$ 29.02
